In vivo adenosine receptor preconditioning reduces myocardial infarct size via subcellular ERK signaling

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 288, Issue 5 57-5, 2005, Pages

  Reid, Easton A ^a   Kristo, Gentian ^a   Yoshimura, Yukihiro ^a   Ballard Croft, Cherry ^a   Keith, Byron J ^a   Mentzer Jr , Robert M ^a   Lasley, Robert D ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Adenosine; Compartmentation; Ischemia reperfusion; Myocardium

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 4 [2 [7 AMINO 2 (2 FURYL) 1,2,4 TRIAZOLO[2,3 A][1,3,5]TRIAZIN 5 YLAMINO]ETHYL]PHENOL; 4 [7 [[1 [(3 CHLORO 2 THIENYL)METHYL]PROPYL]AMINO] 3H IMIDAZO[4,5 B]PYRIDIN 3 YL] N ETHYL 2,3 DIHYDROXYCYCLOPENTANECARBOXAMIDE; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ADENOSINE; ADENOSINE A1 RECEPTOR AGONIST; ADENOSINE A1 RECEPTOR ANTAGONIST; ADENOSINE A2A RECEPTOR AGONIST; ADENOSINE RECEPTOR; ISOENZYME; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL FRACTIONATION; CELL MEMBRANE; CELL NUCLEUS; CONTROLLED STUDY; CYTOSOL; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HEART INFARCTION; HEART INFARCTION PREVENTION; HEART INFARCTION SIZE; HEART MUSCLE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; IN VIVO STUDY; MITOCHONDRION; MYOFILAMENT; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; SIGNAL TRANSDUCTION;

ANIMALS; BUTADIENES; ENZYME INHIBITORS; IMIDAZOLES; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MYOCARDIAL INFARCTION; NITRILES; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, PURINERGIC P1; REPERFUSION INJURY; SUBCELLULAR FRACTIONS; TRIAZINES; TRIAZOLES; XANTHINES;

EID: 18044384663     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.01009.2004     Document Type: Article

References (37)

1. Abe T, Morgan DA, and Gutterman DD. Role of adenosine receptor subtypes in neural stunning of sympathetic coronary innervation. Am J Physiol Heart Circ Physiol 272: H25-H34, 1997.
2. Armstrong SC. Protein kinase activation and myocardial ischemia/reperfusion injury. Cardiovasc Res 61: 427-436, 2004.
3. Baines CP, Zhang J, Wang G, Zheng Y, Xiu JX, Cardwell EM, Bolli R, and Ping P. Mitochondria PKCε and MAPK form signaling modules in murine heart: enhanced mitochondrial PKCε-MAPK interactions and differential MAPK activation in PKCε-induced cardioprotection. Circ Res 90: 390-397, 2002.
4. Bogoyevitch MA, Ng DC, Court NW, Draper KA, Dhillon A, and Abas L. Intact mitochondrial electron transport function is essential for signalling by hydrogen peroxide in cardiac myocytes. J Mol Cell Cardiol 32: 1469-1480, 2000.
5. Cohen MV, Baines CP, and Downey JM. Ischemic preconditioning: from adenosine receptor to KATP channel. Annu Rev Physiol 62: 79-109, 2000.
6. da Silva R, Grampp T, Pasch T, Schaub MC, and Zaugg M. Differential activation of mitogen-activated protein kinases in ischemic and anesthetic preconditioning. Anesthesiology 100: 59-69, 2004.
7. Fryer RM, Pratt PF, Hsu AK, and Gross GJ. Differential activation of extracellular signal regulated kinase isoforms in preconditioning and opioid-induced cardioprotection. J Pharmacol Exp Ther 296: 642-649, 2001.
8. Germack R and Dickenson JM. Characterization of ERK 1/2 signaling pathways induced by adenosine receptor subtypes in newborn rat cardiomyocytes. Br J Pharmacol 141: 329-339, 2004.
9. Henry P, Demolombe S, Puceat M, and Escande D. Adenosine A1 stimulation activates delta-protein kinase C in rat ventricular myocytes. Circ Res 78: 161-165, 1996.
10. 2a receptor activation fails to alter cAMP or contractility: role of receptor localization. Am J Physiol Heart Circ Physiol 282: H1035-H1040, 2002.
11. Kis A, Baxter GF, and Yellon DM. Limitation of myocardial reperfusion injury by AMP-579, an adenosine A1/A2A receptor agonist: role of A2A receptor and Erk1/2. Cardiovasc Drugs Ther 17: 415-425, 2003.
12. Kristo G, Yoshimura Y, Keith BJ, Stevens RM, Jahania SA, Mentzer RM, Jr, and Lasley RD. The adenosine A1/A receptor agonist AMP-5792A induces both acute, and delayed preconditioning against in vivo myocardial stunning. Am J Physiol Heart Circ Physiol 287: H2746-H2753, 2004.
13. Lasley RD, Narayan P, and Mentzer RM Jr. New insights into adenosine receptor modulation of myocardial ischemia-reperfusion injury. Drug Dev Res 52: 357-365, 2001.
14. ATP channel. Am J Physiol Heart Circ Physiol 273: H847-H853, 1997.
15. Lips DJ, Bueno OF, Wilkins BJ, Purcell NH, Kaiser RA, Lorenz JN, Voisin LV, Saga-El-Deil MK, Meloche, S, Pouyséegur J, Pagès G, De Windt LJ, Doevendans PA, and Molkentin JD. MEK1-ERK2 Signaling pathway protects myocardium from ischemic injury in vivo. Circulation 109: 1938-1941, 2004.
16. +-ATPase. Am J Physiol Cell Physiol 284: C1550-C1560, 2003.
17. Lopes LV, Cunha RA, Kull B, Fredholm BB, and Ribeiro JA. Adenosine A(2A) receptor facilitation of hippocampal synaptic transmission is dependent on tonic A(1) receptor inhibition. Neuroscience 112: 319-329, 2002.
18. Lopes LV, Cunha RA, and Mibeiro JA. ZM241385, an adenosine A(2A) receptor antagonist, inhibits hippocampal A(1) receptor responses. Eur J Pharmacol 383: 395-398, 1999.
19. Luttrell LM. Activation and targeting of mitogen-activated protein kinases by G-protein-coupled receptors. Can J Physiol Pharmacol 80: 375-382, 2002.
20. Michel MC, Li Y, and Heusch G. Mitogen-activated protein kinases in the heart. Naunyn Schmiedebergs Arch Pharmacol 363: 245-266, 2001.
21. Mizukami Y and Yoshida K. Mitogen-activated protein kinase translocates to the nucleus during ischaemia and is activated during reperfusion. Biochem J 323: 785-790, 1997.
22. Mubagwa K and Flameng W. Adenosine, adenosine receptors and myocardial protection: an updated overview. Cardiovasc Res 52: 25-39, 2001.
23. Omura T, Yoshiyama M, Shimada T, Shimizu N, Kim S, Iwao H, Takeuchi K, and Yoshikawa J. Activation of mitogen-activated protein kinases in in vivo ischemia/reperfused myocardium in rats. J Mol Cell Cardiol 31: 1269-1279, 1999.
24. Ping P, Zhang J, Cao X, Li RC, Kong D, Tang XL, Qiu Y, Manchikalapudi S, Auchampach JA, Black RG, and Bolli R. PKC-dependent activation of p44/p42 MAPKs during myocardial ischemia-reperfusion in conscious rabbits. Am J Physiol Heart Circ Physiol 276: H1468-H1481, 1999.
25. Robinson AJ and Dickenson JM. Regulation of p42/p44 MAPK and p38 MAPK by the adenosine A1 receptor in DDT1MF-2 cells. Eur J Pharmacol 413: 151-161, 2001.
26. 2+ overload in NRVM involves ERK1/2 MAP kinases: role for an NHE-1-dependent pathway. Am J Physiol Heart Circ Physiol 283: H598-H605, 2002.
27. Rybin VO, Xu X, and Steinberg SF. Activated protein kinase C isoforms target to cardiomyocyte caveolae: stimulation of local protein phosphorylation. Circ Res 84: 980-988, 1999.
28. ATP channel openers activate the ERK kinase by an oxidant-dependent mechanism. Am J Physiol Cell Physiol 283: C273-C281, 2002.
29. Schulte G and Fredholm BB. Signalling from adenosine receptors to mitogen-activated protein kinases. Cell Signal 15: 813-827, 2003.
30. Sexl V, Mancusi G, Holler C, Gloria-Maercker E, Schutz W, and Freissmuth M. Stimulation of the mitogen-activated protein kinase via the A2A-adenosine receptor in primary human endothelial cells. J Biol Chem 272: 5792-5799, 1997.
31. Smits GJ, McVey M, Cox BF, Perrone MH, and Clark KL. Cardioprotective effects of the novel adenosine A1/A2 receptor agonist AMP 579 in a porcine model of myocardial infarction. J Pharmacol Exp Ther 286: 611-618, 1998.
32. Strohm C, Barancik T, Bruhl ML, Kilian SA, and Schaper W. Inhibition of the ER-kinase cascade by PD98059 and UO126 counteracts ischemic preconditioning in pig myocardium. J Cardiovasc Pharmacol 36: 218-229, 2000.
33. 2 in rat cardiac myocytes. Am J Physiol Cell Physiol 281: C1542-C1550, 2001.
34. Xu Z, Downey JM, and Cohen MV. AMP 579 reduces contracture and limits infarction in rabbit heart by activating adenosine A2 receptors. J Cardiovasc Pharmacol 38: 474-481, 2001.
35. Xu Z, Ji X, and Boysen PG. Exogenous nitric oxide generates ROS and induces cardioprotection: involvement of PKG, mitochondrial KATP channels, and ERK. Am J Physiol Heart Circ Physiol 286: H1433-H1440, 2004.
36. Yang XM, Krieg T, Cui L, Downey JM, and Cohen MV. NECA and bradykinin at reperfusion reduce infarction in rabbit hearts by signaling through PI3K, ERK, and NO. J Mol Cell Cardiol 36: 411-421, 2004.
37. Yue T, Wang C, Gu J, MX, Kumar S, Lee JC, Feuerstein GZ, Thomas H, Maleeff B, and Ohlstein EH. Inhibition of extracellular signal-regulated kinase enhances ischemia/reoxygenation-induced apoptosis in cultured cardiac myocytes and exaggerates reperfusion injury in isolated perfused heart. Circ Res 86: 692-699, 2000.